Past Papers · SAQ

Sedatives — Propofol vs Midazolam

Current · V5 (2025) → H6.i Historical · V4 (2023) → K2.i 1 exam appearance

2019B Q09

Exam question

Compare and contrast the pharmacology of propofol and midazolam.

CICMWrecks answer

Master answer

Canonical sourceCanonical Pharmacopeia comparison
Open in Pharmacopeia
Canonical comparison

Master Compare

Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.

2selected
Comparing 2 of 2 drugs
× ×
Change selection
2 drug columns · use arrows or scrollbar
Field PROPOFOL
Neurology & Sedation · Neurology & Sedation · Level 1
Midazolam
Neurology & Sedation · Neurology & Sedation · Level 1
Mechanism of action

selective modulation of GABA-A receptor (agonism)
(distinct from modulatory site for barbiturates and benzos, and GABA itself)
- Influx of Cl- into nerve cell
- Hyperpolarised, preventing conduction

increases the sensitivity GABAA receptors which open (via GABA) and allow Cl influx
causing hyperpolarisation
- Influx of Cl- into nerve cell
- Hyperpolarised, preventing conduction

Physiological effects

CNS: Sedation and hypnosis
(Rapid distribution across BBB)
No analgesia
Burst suppression
Decreases cerebral VO2, blood flow and ICP
CVS: signifi¬cant drop in BP due to decreased TPR, but without a reflex tachycardia (infusion
rate dependent)
Resp: Dose dependent resp depression, apnoea
GIT: Anti-emetic

CNS: Sedative, reduces epileptiform activity,
increases confusion and disorientation, amnesic properties more prominent than
sedative eff¬ects
CVS: minor hypotension has been reported

Resp: respiratory depression - synergistic with opioids

Absorption

A: onset / duration 30 seconds / 3-10 minutes

A : IV,PO,In,IM
poor oral bioavailability 45%

Distribution

pKa 11
very high lipid sol
Crosses placenta

lipid soluble at physiological pH (pKa 6.5).
high lipid sol crosses BBB

Protein binding

97-99%

Approximately 96% protein-bound in plasma.

Volume of distribution

2-10L/kg
60l/kg after 10 day infusion
↓ in elderly

Volume of distribution approximately 0.8-1.5 L/kg, increasing to about 3.1 L/kg in critically ill patients.

Metabolism

Hepatic to partially inactive metabolites (water soluble sulfate and glucuronide conjugates(~50%)
Clearance > liver blood flow, ∴extrahepatic metabolism

hepatic via CYP3A4, and glucuronidation
active metabolite

Excretion

Urine (~88% as metabolites,40% as glucuronide)

excreted in urine (as glucuronide conjugated metabolites)

Half-life

half life Biphasic: Initial 40 min; Terminal 4-7 hrs (up to 60hrs)

half life 1-4 hrs
prolonged in cirrhosis, CRF, CCF, obesity, elderly

Adverse Effects Toxicity

Hypotension (baroreceptor sens.
blunted, decreased sympathetic tone). Painful on injection.
Propofol syndrome: Metabolic acidosis, hyperlipidaemia, myocardial failure, death- common in children

Respiratory depression and excessive sedation with overdosage
Same CYP as alfentanil (increases e¬ffect)

Chemical Pharmaceutics —

- Imidazole ring in its structure - Accounts for water solubility And rapid metabolism
- 2-3x potent Diazepam

Class Group

Sedative / Hypnotic

Anticonvulsant Sedative-Hypnotic

Indications Uses

Short term sedation
Induction and maintenance of anaesthesia
Maintenance of sedation

Sedative, amnesic+ anxiolytic,
antiepileptic

Introduction

2,6-di-isopropyl phenol Chemically inert phenolic derivative

- Benzodiazepine
- Imidazole ring in its structure - Accounts for water solubility And rapid metabolism
- 2-3x potent Diazepam

Legacy Cicm Level

Level 1

Level 1

Presentation

Milky white emulsion 1%
Soya bean lipid/Egg phosphatide
Sodium hydroxide
Weak org acid pKa 11- unionised

Clear solution pH 3.5 (IV/IM), Tablet
pKa 6.5 – 89% un-ionized

Route And Dose

Induction: 2-2.5mg/kg
Maintenance: 1-5mg/kg/hour
Both sig. less in critically ill

2-2.5mg initially then 1mg boluses to eff¬ect

Past papers

Exam appearances

1 appearance
Exam Exact exam wording Candidate success
2019B Q09 Compare and contrast the pharmacology of propofol and midazolam. 77%